Adela Hruby1, Jiantao Ma1,2, Gail Rogers1, James B Meigs3, Paul F Jacques4. 1. Nutritional Epidemiology, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, and Tufts University Friedman School of Nutrition Science and Policy, Boston, MA. 2. National Heart, Lung, and Blood Institute, Framingham Heart Study, Framingham, MA; and. 3. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA. 4. Nutritional Epidemiology, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, and Tufts University Friedman School of Nutrition Science and Policy, Boston, MA; paul.jacques@tufts.edu.
Abstract
Background: Inconsistent evidence describes the association between dietary intake of dairy and milk-based products and type 2 diabetes (T2D) risk.Objective: Our objective was to assess associations between consumption of milk-based products, incident prediabetes, and progression to T2D in the Framingham Heart Study Offspring Cohort. Methods: Total dairy and milk-based product consumption was assessed by ≤4 food-frequency questionnaires across a mean of 12 y of follow-up in 2809 participants [mean ± SD age: 54.0 ± 9.7 y; body mass index (in kg/m2): 27.1 ± 4.7; 54% female]. Prediabetes was defined as the first occurrence of fasting plasma glucose ≥5.6 to <7.0 mmol/L (≥100 to <126 mg/dL), and T2D was defined as the first occurrence of fasting plasma glucose ≥7.0 mmol/L (≥126 mg/dL) or diabetes treatment. Proportional hazards models were used to estimate the risk of incident outcomes relative to dairy product intake in subsets of the cohort who were at risk of developing the outcomes. Spline regressions were used to examine potential nonlinear relations. Results: Of 1867 participants free of prediabetes at baseline, 902 (48%) developed prediabetes. Total, low-fat, and high-fat dairy consumptions were associated with a 39%, 32%, and 25% lower risk of incident prediabetes, respectively, in the highest compared with the lowest intakes (≥14 compared with <4 servings/wk). Total, low-fat and skim milk, whole-milk, and yogurt intakes were associated nonlinearly with incident prediabetes; moderate intake was associated with the greatest relative risk reduction. Neither cheese nor cream and butter was associated with prediabetes. Of 925 participants with prediabetes at baseline, 196 (21%) developed T2D. Only high-fat dairy and cheese showed evidence of dose-response, inverse associations with incident T2D, with 70% and 63% lower risk, respectively, of incident T2D between the highest and lowest intake categories (≥14 compared with <1 serving/wk for high-fat dairy, ≥4 compared with <1 serving/wk for cheese). Conclusion: Associations of dairy with incident prediabetes or diabetes varied both by dairy product and type and by baseline glycemic status in this middle-aged US population. Baseline glycemic status may partially underlie prior equivocal evidence regarding the role of dairy intake in diabetes.
Background: Inconsistent evidence describes the association between dietary intake of dairy and milk-based products and type 2 diabetes (T2D) risk.Objective: Our objective was to assess associations between consumption of milk-based products, incident prediabetes, and progression to T2D in the Framingham Heart Study Offspring Cohort. Methods: Total dairy and milk-based product consumption was assessed by ≤4 food-frequency questionnaires across a mean of 12 y of follow-up in 2809 participants [mean ± SD age: 54.0 ± 9.7 y; body mass index (in kg/m2): 27.1 ± 4.7; 54% female]. Prediabetes was defined as the first occurrence of fasting plasma glucose ≥5.6 to <7.0 mmol/L (≥100 to <126 mg/dL), and T2D was defined as the first occurrence of fasting plasma glucose ≥7.0 mmol/L (≥126 mg/dL) or diabetes treatment. Proportional hazards models were used to estimate the risk of incident outcomes relative to dairy product intake in subsets of the cohort who were at risk of developing the outcomes. Spline regressions were used to examine potential nonlinear relations. Results: Of 1867 participants free of prediabetes at baseline, 902 (48%) developed prediabetes. Total, low-fat, and high-fat dairy consumptions were associated with a 39%, 32%, and 25% lower risk of incident prediabetes, respectively, in the highest compared with the lowest intakes (≥14 compared with <4 servings/wk). Total, low-fat and skim milk, whole-milk, and yogurt intakes were associated nonlinearly with incident prediabetes; moderate intake was associated with the greatest relative risk reduction. Neither cheese nor cream and butter was associated with prediabetes. Of 925 participants with prediabetes at baseline, 196 (21%) developed T2D. Only high-fat dairy and cheese showed evidence of dose-response, inverse associations with incident T2D, with 70% and 63% lower risk, respectively, of incident T2D between the highest and lowest intake categories (≥14 compared with <1 serving/wk for high-fat dairy, ≥4 compared with <1 serving/wk for cheese). Conclusion: Associations of dairy with incident prediabetes or diabetes varied both by dairy product and type and by baseline glycemic status in this middle-aged US population. Baseline glycemic status may partially underlie prior equivocal evidence regarding the role of dairy intake in diabetes.
Authors: Simone J P M Eussen; Martien C J M van Dongen; Nicole Wijckmans; Louise den Biggelaar; Stefanie J W H Oude Elferink; Cécile M Singh-Povel; Miranda T Schram; Simone J S Sep; Carla J van der Kallen; Annemarie Koster; Nicolaas Schaper; Ronald M A Henry; Coen D A Stehouwer; Pieter C Dagnelie Journal: Br J Nutr Date: 2016-02-24 Impact factor: 3.718
Authors: Lieke Gijsbers; Eric L Ding; Vasanti S Malik; Janette de Goede; Johanna M Geleijnse; Sabita S Soedamah-Muthu Journal: Am J Clin Nutr Date: 2016-02-24 Impact factor: 7.045
Authors: Carmen Sayon-Orea; Miguel A Martínez-González; Miguel Ruiz-Canela; Maira Bes-Rastrollo Journal: Adv Nutr Date: 2017-01-17 Impact factor: 8.701
Authors: S Salvini; D J Hunter; L Sampson; M J Stampfer; G A Colditz; B Rosner; W C Willett Journal: Int J Epidemiol Date: 1989-12 Impact factor: 7.196
Authors: Mu Chen; Qi Sun; Edward Giovannucci; Dariush Mozaffarian; JoAnn E Manson; Walter C Willett; Frank B Hu Journal: BMC Med Date: 2014-11-25 Impact factor: 8.775
Authors: Marcia C de Oliveira Otto; Jennifer A Nettleton; Rozenn N Lemaitre; Lyn M Steffen; Daan Kromhout; Stephen S Rich; Michael Y Tsai; David R Jacobs; Dariush Mozaffarian Journal: J Am Heart Assoc Date: 2013-07-18 Impact factor: 5.501
Authors: Judit Companys; Laura Pla-Pagà; Lorena Calderón-Pérez; Elisabet Llauradó; Rosa Solà; Anna Pedret; Rosa M Valls Journal: Adv Nutr Date: 2020-07-01 Impact factor: 8.701
Authors: Kim Kummer; Paul N Jensen; Mario Kratz; Rozenn N Lemaitre; Barbara V Howard; Shelley A Cole; Amanda M Fretts Journal: J Nutr Date: 2019-07-01 Impact factor: 4.798
Authors: Kristen M Sochol; Tanya S Johns; Rupinder S Buttar; Lovepreet Randhawa; Edeline Sanchez; Maya Gal; Katherine Lestrade; Massini Merzkani; Matthew K Abramowitz; Yasmin Mossavar-Rahmani; Michal L Melamed Journal: Nutrients Date: 2019-09-17 Impact factor: 5.717
Authors: Jing Guo; D Ian Givens; Arne Astrup; Stephan J L Bakker; Gijs H Goossens; Mario Kratz; André Marette; Hanno Pijl; Sabita S Soedamah-Muthu Journal: Adv Nutr Date: 2019-11-01 Impact factor: 8.701
Authors: Carla Assaf-Balut; Nuria Garcia de la Torre; Elena Bordiu; Laura Del Valle; Johanna Valerio; Inés Jimenez; Alejandra Duran; Manuel Fuentes; Miguel Angel Herraiz; Nuria Izquierdo; Isabelle Runkle; Paz de Miguel; Cristina Familiar; Maria Carmen Montañez; Ana Barabash; Veronica Melero; Martín Cuesta; Miguel Rubio; Alfonso Luis Calle-Pascual Journal: BMJ Open Diabetes Res Care Date: 2020-04